Next 10 |
2024-05-10 09:53:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ImmunityBio (NASDAQ: IBRX ) just reported results for the first quarter of 2024. ImmunityBio reported earnings per share of -20 cents. This was below the analyst estimate ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in Dunkirk, New York on track to be completed in 12-18 months with capacity to produc...
2024-05-03 15:54:13 ET Summary CG Oncology has entered the public market with late-stage clinical trials for its cancer therapy, cretostimogene grenadenorepvec. The company is focused on treating non-muscle-invasive bladder cancer, an area of unmet need due to a shortage of standa...
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatment for non-muscle invasive bladder cancer (NMIBC) Serum Institute of India (SII) will manufacture both standard BCG (“sBCG”) and n...
Dr. Sam S. Chang, Professor of Urology at Vanderbilt Cancer Program, to host the program “A Deep Dive with Patrick Soon-Shiong: Next-Generation Immunotherapy for NMBIC” Discussion about the basis for ANKTIVA’s Breakthrough Therapy designation and the novel mechanism o...
2024-04-29 11:26:05 ET ImmunityBio (NASDAQ: IBRX) stock price has gone parabolic as investors cheer the recent approval of Anktiva , its cancer drug. It has risen for two straight days and is now sitting at its highest level since September 2021. It is up by over 770% from its l...
2024-04-29 10:02:54 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...
A look at the top 10 most actives in the United States SoFi Technologies Inc. (SOFI) fell 9.7% to $7.1068 on volume of 45,729,887 shares Tesla Inc. (TSLA) rose 11.6% to $187.7701 on volume of 45,057,076 shares Collective Audience Inc. (CAUD) rose 71.6% to $0.669199 on volume of 34,955,653...
2024-04-29 08:36:50 ET More on premarket gainers & stock Diving Into Deciphera Pharmaceuticals Fulton Financial Corporation (FULT) Q1 2024 Earnings Call Transcript Fulton Financial Corporation 2024 Q1 - Results - Earnings Call Presentation Fulton Financia...
News, Short Squeeze, Breakout and More Instantly...
ImmunityBio Inc. Company Name:
IBRX Stock Symbol:
NASDAQ Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday. Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply d...